Press Releases

Since autumn 2015, the Zika virus epidemic has been causing marked increases in the birth of babies with much too small heads, or so-called “microcephaly”, especially in South and Central America. The

Researchers of the University of Tübingen and DZIF in collaboration with the biotech company Sanaria Inc. have demonstrated in a clinical trial that a new vaccine for malaria called Sanaria® PfSPZ

Almost everybody has it: Scientists estimate that approximately 98 percent of adults around the world are infected with the Epstein-Barr virus. In rare cases, an infection with this virus causes

Severe malaria, caused by the Plasmodium falciparum parasite, causes dangerous circulatory disorders and neurological complications. If the affected person is not treated immediately, the disease will

Colistin is used as the “last-resort antibiotic” for dreaded multidrug-resistant pathogens, especially in hospitals. However, gut bacteria that have become insensitive to colistin now exist—owing to

An international team of scientists has sequenced the genomes of two rare malaria pathogens, both parasites of the plasmodium species. A scientist from the Bernhard Nocht Institute for Tropical

Heidelberg virologist Prof Ralf Bartenschlager has received Science Award of the Hector-Stiftung, worth 150,000 euros.

With this, the Hector Stiftung’s jury honours Bartenschlager’s outstanding

Scientists from the University of Tübingen and the German Center of Infection Research (DZIF) have been able to demonstrate that sugar polymers on the outer cell envelope of Staphylococcus aureus mean

The recent Ebola crisis has triggered global rethinking: the global community wants to be better prepared for serious infectious disease epidemics than before. For this purpose, the international

A research team led by investigators of the Rockefeller University in New York and Prof Florian Klein, University Hospital Cologne and German Center for Infection Research (DZIF), has tested a new HIV